{"id":"W3005570342","doi":"10.1634/theoncologist.2019-0674","title":"Anti-PD1-Induced Immune-Related Adverse Events and Survival Outcomes in Advanced Melanoma","year":2020,"lang":"en","type":"article","venue":"The Oncologist","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"Alberta Cancer Foundation","keywords":"Medicine; Nivolumab; Adverse effect; Pembrolizumab; Pneumonitis; Hazard ratio; Ipilimumab; Internal medicine; Melanoma; Cancer; Immunotherapy; Confidence interval; Lung","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003469789,0.0001533628,0.0004494771,0.00003539033,0.00007772815,0.000004357985,0.0001412614,0.0001039043,0.0001155913],"category_scores_gemma":[0.0001394983,0.00009587307,0.0001069028,0.0002482607,0.0001428554,0.0000549318,0.00006938997,0.0002425707,0.00002708073],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001029632,"about_ca_system_score_gemma":0.00008131965,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003113689,"about_ca_topic_score_gemma":0.00009590297,"domain_scores_codex":[0.9989424,0.0001095914,0.0003549126,0.0002208597,0.0001535328,0.0002187512],"domain_scores_gemma":[0.9994481,0.0001242219,0.0001192662,0.0002178104,0.00002158866,0.00006903194],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006113067,0.0003803267,0.7659393,0.0000752702,0.0004796703,0.0002330116,0.001977296,0.00001876974,0.1861007,0.0001377983,0.0001543759,0.03839041],"study_design_scores_gemma":[0.007700016,0.0008066274,0.9866074,0.00004512849,0.00005388146,0.00001767239,0.0007981452,0.00008598569,0.001855511,0.00003974041,0.001852211,0.0001376273],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9815397,0.0005016867,0.000002966245,0.01417598,0.0003073779,0.0004880266,0.000006407549,0.00006081245,0.002917015],"genre_scores_gemma":[0.9979396,0.0002408549,0.00005803919,0.001234495,0.00003092337,0.00001724603,0.00000946726,0.00001585496,0.0004534652],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2206682,"threshold_uncertainty_score":0.3909591,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03187919730524732,"score_gpt":0.3117223201264311,"score_spread":0.2798431228211838,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}